Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Cash & Current Investments (2016 - 2025)

Xtant Medical Holdings has reported Cash & Current Investments over the past 16 years, most recently at $17.3 million for Q4 2025.

  • Quarterly Cash & Current Investments rose 178.54% to $17.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.3 million through Dec 2025, up 178.54% year-over-year, with the annual reading at $17.3 million for FY2025, 178.54% up from the prior year.
  • Cash & Current Investments was $17.3 million for Q4 2025 at Xtant Medical Holdings, up from $10.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $20.5 million in Q2 2021 and troughed at $4.4 million in Q2 2023.
  • The 5-year median for Cash & Current Investments is $9.7 million (2023), against an average of $11.8 million.
  • Year-over-year, Cash & Current Investments soared 685.43% in 2021 and then crashed 73.6% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $18.4 million in 2021, then grew by 11.53% to $20.5 million in 2022, then plummeted by 71.12% to $5.9 million in 2023, then grew by 5.03% to $6.2 million in 2024, then skyrocketed by 178.54% to $17.3 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Cash & Current Investments are $17.3 million (Q4 2025), $10.6 million (Q3 2025), and $7.0 million (Q2 2025).